The MarketWatch News Department was not involved in the creation of this content. -- Key presentation unveiled Acuitas' Next-Generation LNP Advancements, which is designed to enhance potency and ...
April 25 (Reuters) - Biotech company Acuitas Therapeutics and Germany-based CureVac (5CV.DE), opens new tab have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, ...
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE CVAC, accusing it of failing to credit Acuitas on patents related to COVID-19 ...
CHARLOTTETOWN, Prince Edward Island & VANCOUVER, British Columbia--(BUSINESS WIRE)--BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results